Dr. Chancellor Donald is the Chief Medical Officer of the Taking Aim at Cancer in Louisiana initiative. He currently holds the position of Assistant Professor of Clinical Medicine at Tulane University School of Medicine and serves as Medical Director of Tulane Cancer Management and Oncology Services at University Medical Center in New Orleans. His academic focus is advocacy and health disparities regarding patients with hematologic disorders and malignancy. He previously cared for patients in a community practice at Lourdes Oncology Associates in Lafayette, Louisiana.
Formed by the Louisiana Department of Health, the TakingAim at Cancer in Louisiana initiative aims to improve the cancer outcomes of citizens of the state. As a lead, Dr. Donald engages and builds consensus with key stakeholders. In this role he guides and aligns strategies and champions policies aimed at improving measurable cancer care metrics in Louisiana.
Originally from Gretna, Florida, Dr. Donald attended Florida A&M University for undergraduate studies and graduated magna cumlaude. He then attended the University of Miami School of Medicine for his medical degree. He completed his internship, residency and fellowship at Tulane University. He was selected as Chief Resident and Chief Fellow during his training.
In 2010 he joined Louisiana Oncology Associates, PMC and became President of the practice in 2014. Dr. Donald would subsequently serve as a lead in crafting a professional services agreement with Our Lady of Lourdes Regional Medical Center. While at Our Lady of Lourdes Regional Medical Center, he functioned as Medical Director of the oncology service line, a Member of the Medical Executive Committee and as a Trustee on the Board of Directors at that institution. In 2013, he was given the Spirit of Hope Award by the American Cancer Society.
Dr. Donald was awarded the Exemplary Service Award by the American Society of Hematology in 2022. He serves as Chair of the Committee on Practice for the American Society of Hematology. He also holds the position of the American Society of Hematology’s delegate to the American Medical Association’s House of Delegates and alternate to the AMA CPT Editorial Advisory Committee.
In 2022, Dr. Donald was selected for the Government Relations Committee for the American Society of Clinical Oncology. He was recognized as an Advocacy Champion by ASCO in 2020 and 2022. Since 2012 he has served as the Hematology Representative for Louisiana for the Medicare Carrier Advisory Committee (CAC). He also serves on the American Board of Internal Medicine’s Hematology Examination Approval Committee and maintains current ABIM certification in Internal Medicine, Hematology and Medical Oncology.